fbpx

ZIM Laboratories Ltd

ZIML.NS

$1.21

Closing

▲3.60%

1D

▼-2.80%

YTD

ZIML

BBG001TTNYD8

Exchange

Sector

Market cap

$58.95M

Volume

74,200

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$58.95M

Analysts' Rating

-

Price Target (Mean)

0.00

Total Analysts

0

P/E

31.58

Operating Margin

6.96%

Beta

Revenue Growth

7.36%

52 week high

$1.52

52 week low

$1.04

Div. Yield

%

EPS Growth

0.00

Company Profile

ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.